|
|
intracellular bile acid receptor signaling pathway
|
GO:0038185 |
1 |
1.000
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
1.000
|
|
|
|
drug catabolic process
|
GO:0042737 |
10 |
1.000
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
1.000
|
|
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
1.000
|
|
|
|
negative regulation of cholesterol storage
|
GO:0010887 |
4 |
1.000
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
1.000
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003256 |
3 |
0.999
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.999
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.999
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.999
|
|
|
|
histone deacetylation
|
GO:0016575 |
32 |
0.999
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.999
|
|
|
|
regulation of glycolytic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072361 |
2 |
0.999
|
Human |
|
|
chromatin modification
|
GO:0016568 |
298 |
0.998
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.996
|
Zebrafish |
|
|
protein deacetylation
|
GO:0006476 |
38 |
0.996
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.993
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.992
|
Mouse |
|
|
xenobiotic transport
|
GO:0042908 |
1 |
0.989
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.989
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.989
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.987
|
Zebrafish |
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.985
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.985
|
Rat |
|
|
immune system development
|
GO:0002520 |
195 |
0.984
|
Zebrafish |
|
|
nervous system development
|
GO:0007399 |
293 |
0.981
|
Mouse |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.979
|
|
|
|
regulation of lipid transport by regulation of transcription from rna polymerase ii promoter
|
GO:0072367 |
4 |
0.979
|
Human |
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.979
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.977
|
Mouse |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.976
|
Rat |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.976
|
Mouse |
|
|
regulation of receptor biosynthetic process
|
GO:0010869 |
15 |
0.975
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.975
|
|
|
|
positive regulation of vitamin d 24 hydroxylase activity
|
GO:0010980 |
3 |
0.974
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.973
|
Rat |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.973
|
|
|
|
memory
|
GO:0007613 |
3 |
0.972
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.970
|
|
|
|
mating
|
GO:0007618 |
1 |
0.970
|
|
|
|
t helper 2 cell differentiation
|
GO:0045064 |
1 |
0.970
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.970
|
|
|
|
protein deacylation
|
GO:0035601 |
39 |
0.966
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.963
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.962
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
8 |
0.954
|
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.949
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
4 |
0.948
|
|
|
|
drug transport
|
GO:0015893 |
8 |
0.945
|
|
|
|
cellular response to nutrient
|
GO:0031670 |
12 |
0.936
|
|
|
|
negative regulation of response to interferon gamma
|
GO:0060331 |
2 |
0.931
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.927
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.925
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.923
|
Mouse |
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
3 |
0.914
|
|
|
|
glycolytic process
|
GO:0006096 |
17 |
0.914
|
Human |
|
|
macromolecule deacylation
|
GO:0098732 |
41 |
0.914
|
|
|
|
regulation of glycolytic by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072363 |
1 |
0.913
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.912
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.912
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.906
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
30 |
0.906
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.905
|
|
|
|
nephric duct development
|
GO:0072176 |
4 |
0.903
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.900
|
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
8 |
0.896
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.895
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.891
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.891
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
4 |
0.889
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.888
|
Mouse |
|
|
regulation of t helper cell differentiation
|
GO:0045622 |
3 |
0.886
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.881
|
|
|
|
lung epithelium development
|
GO:0060428 |
7 |
0.880
|
Mouse |
|
|
alpha beta t cell differentiation
|
GO:0046632 |
7 |
0.877
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.877
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.873
|
Human |
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.872
|
Human |
|
|
epidermis development
|
GO:0008544 |
59 |
0.871
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.866
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.865
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.864
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.862
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.859
|
|
|
|
cell migration involved in sprouting angiogenesis
|
GO:0002042 |
19 |
0.859
|
|
|
|
system process
|
GO:0003008 |
349 |
0.854
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.851
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.850
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.841
|
|
|
|
negative regulation of bile acid biosynthetic process
|
GO:0070858 |
3 |
0.840
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.840
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.833
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.832
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.820
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
5 |
0.811
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.800
|
Mouse |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.797
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.797
|
Rat |
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.794
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.794
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.794
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.793
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.790
|
Human |
|
|
muscle structure development
|
GO:0061061 |
98 |
0.784
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.777
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
11 |
0.774
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.774
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.772
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.769
|
|
|
|
negative regulation of type 2 immune response
|
GO:0002829 |
3 |
0.760
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.760
|
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.754
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.753
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
8 |
0.749
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.748
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.746
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.744
|
Mouse |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.744
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.742
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.742
|
|
|
|
secondary heart field specification
|
GO:0003139 |
2 |
0.741
|
|
|
|
positive regulation of epithelial cell differentiation
|
GO:0030858 |
14 |
0.741
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.740
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.739
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.738
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.735
|
Human |
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.735
|
Mouse |
|
|
sequestering of triglyceride
|
GO:0030730 |
11 |
0.733
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.730
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.729
|
|
|
|
regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043370 |
3 |
0.727
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.726
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.726
|
Mouse |
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.722
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.719
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.715
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.712
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.711
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.709
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.705
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.705
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
5 |
0.698
|
|
|
|
drug metabolic process
|
GO:0017144 |
19 |
0.693
|
|
|
|
t cell differentiation
|
GO:0030217 |
29 |
0.693
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.692
|
Mouse |
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.689
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
29 |
0.686
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
47 |
0.684
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
35 |
0.677
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.677
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.674
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
11 |
0.669
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
17 |
0.666
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.663
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.660
|
|
|
|
negative regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0017055 |
2 |
0.656
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
9 |
0.654
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.653
|
|
|
|
bile acid signaling pathway
|
GO:0038183 |
3 |
0.649
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
15 |
0.644
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.643
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.641
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.640
|
|
|
|
regulation of wnt signaling pathway involved in heart development
|
GO:0003307 |
3 |
0.635
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.634
|
Mouse |
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.629
|
Human |
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.625
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.623
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.622
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.618
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.618
|
|
|
|
positive regulation of epidermal cell differentiation
|
GO:0045606 |
8 |
0.612
|
|
|
|
cardiac muscle cell myoblast differentiation
|
GO:0060379 |
5 |
0.608
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.605
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.604
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
4 |
0.600
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.597
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.592
|
Rat |
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.589
|
Mouse |
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.584
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.584
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.582
|
Rat |
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.579
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.570
|
Rat |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.568
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.567
|
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.564
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
3 |
0.563
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.562
|
|
|
|
xenobiotic metabolic process
|
GO:0006805 |
28 |
0.562
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.555
|
|
|
|
rhythmic process
|
GO:0048511 |
31 |
0.548
|
Rat |
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.544
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.542
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.537
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.532
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
21 |
0.525
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.525
|
Mouse |
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.522
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.522
|
|
|
|
circadian rhythm
|
GO:0007623 |
21 |
0.519
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.516
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.515
|
|
|
|
regulation of t helper 2 cell differentiation
|
GO:0045628 |
1 |
0.512
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.511
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.509
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.508
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.506
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.504
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.503
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.502
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.501
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.499
|
|
|
|
regulation of transcription involved in g2 m transition of mitotic cell cycle
|
GO:0000117 |
1 |
0.496
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.492
|
|
|
|
response to alkaloid
|
GO:0043279 |
20 |
0.491
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.491
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.486
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.484
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.484
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.480
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901213 |
6 |
0.477
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.475
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
25 |
0.475
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.470
|
Rat |
|
|
central nervous system development
|
GO:0007417 |
123 |
0.463
|
Mouse |
|
|
response to vitamin d
|
GO:0033280 |
10 |
0.462
|
|
|
|
regulation of cardiac muscle cell differentiation
|
GO:2000725 |
7 |
0.461
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.460
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.459
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
39 |
0.458
|
|
|
|
thalamus development
|
GO:0021794 |
2 |
0.456
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.456
|
|
|
|
negative regulation of myotube differentiation
|
GO:0010832 |
4 |
0.456
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
3 |
0.455
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.445
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.445
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.439
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.438
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.436
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.434
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.431
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.426
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.425
|
|
|
|
positive regulation of cardiac muscle cell differentiation
|
GO:2000727 |
4 |
0.422
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.421
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
1 |
0.420
|
Mouse |
|
|
cellular response to xenobiotic stimulus
|
GO:0071466 |
29 |
0.417
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
5 |
0.412
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.411
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.411
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.405
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.404
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014067 |
4 |
0.403
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.402
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.400
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.398
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
18 |
0.398
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.393
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
9 |
0.392
|
|
|
|
peptidyl lysine deacetylation
|
GO:0034983 |
6 |
0.389
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.387
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.381
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.381
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.379
|
Human |
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.378
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.377
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.375
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.375
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.374
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.372
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
5 |
0.371
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.371
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.370
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.368
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.366
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.365
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.364
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.362
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.362
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.359
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.359
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.356
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.355
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
1 |
0.353
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.353
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.353
|
|
|
|
short term memory
|
GO:0007614 |
1 |
0.351
|
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
2 |
0.350
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.346
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.345
|
Rat |
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.344
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.342
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.336
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.335
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.333
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.332
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
26 |
0.329
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.329
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.329
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.329
|
|
|
|
erythrocyte development
|
GO:0048821 |
3 |
0.328
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.327
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.326
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.325
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.324
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
25 |
0.322
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.322
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.319
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.318
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.313
|
|
|
|
negative regulation of sequestering of triglyceride
|
GO:0010891 |
5 |
0.307
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.306
|
|
|
|
cholesterol storage
|
GO:0010878 |
9 |
0.304
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.302
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.299
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.297
|
|
|
|
foam cell differentiation
|
GO:0090077 |
15 |
0.297
|
|
|
|
respiratory tube development
|
GO:0030323 |
20 |
0.296
|
Mouse |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.289
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.288
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.287
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
6 |
0.285
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
2 |
0.284
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.283
|
|
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
24 |
0.283
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.282
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
4 |
0.280
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.278
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.278
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.278
|
|
|
|
regulation of vitamin d 24 hydroxylase activity
|
GO:0010979 |
3 |
0.277
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.277
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.276
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.275
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.272
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
2 |
0.271
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.271
|
|
|
|
type 2 immune response
|
GO:0042092 |
6 |
0.270
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.268
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.267
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.264
|
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
3 |
0.264
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.263
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.262
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.261
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
18 |
0.261
|
|
|
|
cardiac muscle cell fate commitment
|
GO:0060923 |
4 |
0.260
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.260
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.259
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.258
|
Human |
|
|
lipid transport
|
GO:0006869 |
90 |
0.256
|
Human |
|
|
developmental maturation
|
GO:0021700 |
28 |
0.256
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.254
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
39 |
0.253
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.252
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
17 |
0.249
|
Human |
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.248
|
|
|
|
negative regulation of lipid biosynthetic process
|
GO:0051055 |
22 |
0.244
|
|
|
|
growth
|
GO:0040007 |
202 |
0.243
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
32 |
0.242
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.242
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.242
|
|
|
|
lipid homeostasis
|
GO:0055088 |
39 |
0.240
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.239
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.239
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.237
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.236
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.234
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
29 |
0.233
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.233
|
|
|
|
histone h4 deacetylation
|
GO:0070933 |
8 |
0.232
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.232
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.230
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.228
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.227
|
|
|
|
interferon gamma mediated signaling pathway
|
GO:0060333 |
7 |
0.225
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.224
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.221
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.219
|
|
|
|
regulation of interleukin 5 production
|
GO:0032674 |
6 |
0.219
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.218
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
3 |
0.216
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
15 |
0.215
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.213
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
36 |
0.213
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.213
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.211
|
Mouse |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.211
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.210
|
|
|
|
regulation of appetite
|
GO:0032098 |
1 |
0.210
|
|
|
|
retinoic acid receptor signaling pathway
|
GO:0048384 |
13 |
0.209
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
5 |
0.208
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.208
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.207
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.206
|
Human |
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.205
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.205
|
|
|
|
regulation of carbohydrate catabolic process
|
GO:0043470 |
11 |
0.202
|
Human |
|
|
placenta development
|
GO:0001890 |
10 |
0.201
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
24 |
0.200
|
|
|
|
monocyte differentiation
|
GO:0030224 |
15 |
0.200
|
|
|
|
female pregnancy
|
GO:0007565 |
17 |
0.199
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.198
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.198
|
Human |
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
22 |
0.198
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.198
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.198
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.198
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.197
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.196
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
25 |
0.195
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.194
|
|
|
|
cognition
|
GO:0050890 |
43 |
0.193
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.192
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.192
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.192
|
|
|
|
regulation of myelination
|
GO:0031641 |
1 |
0.189
|
|
|
|
regulation of cellular carbohydrate catabolic process
|
GO:0043471 |
11 |
0.188
|
Human |
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.187
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.186
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.183
|
|
|
|
positive regulation of histone deacetylation
|
GO:0031065 |
6 |
0.183
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.181
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.180
|
|
|
|
nose development
|
GO:0043584 |
2 |
0.178
|
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
6 |
0.177
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.177
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.173
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
1 |
0.173
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.171
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.171
|
|
|
|
negative regulation of lipid storage
|
GO:0010888 |
11 |
0.170
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.169
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.168
|
|
|
|
single organism behavior
|
GO:0044708 |
28 |
0.168
|
|
|
|
positive regulation of protein deacetylation
|
GO:0090312 |
8 |
0.168
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.167
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
5 |
0.167
|
|
|
|
interleukin 4 production
|
GO:0032633 |
7 |
0.167
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.166
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.166
|
|
|
|
head development
|
GO:0060322 |
108 |
0.166
|
Mouse |
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.166
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
23 |
0.164
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.163
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
30 |
0.162
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.162
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
18 |
0.161
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.159
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.158
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.158
|
|
|
|
cellular response to vitamin
|
GO:0071295 |
6 |
0.157
|
|
|
|
response to vitamin
|
GO:0033273 |
13 |
0.157
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.157
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
15 |
0.156
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
3 |
0.155
|
|
|
|
gliogenesis
|
GO:0042063 |
21 |
0.155
|
|
|
|
regulation of bile acid biosynthetic process
|
GO:0070857 |
5 |
0.155
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.155
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.154
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.154
|
|
|
|
biomineral tissue development
|
GO:0031214 |
39 |
0.154
|
|
|
|
response to retinoic acid
|
GO:0032526 |
33 |
0.154
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.153
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.152
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.152
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.151
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
13 |
0.150
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.150
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.149
|
|
|
|
myotube differentiation
|
GO:0014902 |
22 |
0.149
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.145
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.145
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.141
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.141
|
|
|
|
cardiac vascular smooth muscle cell differentiation
|
GO:0060947 |
2 |
0.141
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
3 |
0.141
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.140
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.140
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.140
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
29 |
0.140
|
|
|
|
lung development
|
GO:0030324 |
20 |
0.140
|
Mouse |
|
|
retina development in camera type eye
|
GO:0060041 |
15 |
0.140
|
|
|
|
maternal placenta development
|
GO:0001893 |
5 |
0.139
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.139
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.139
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.138
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.137
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
11 |
0.137
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.137
|
Mouse |
|
|
alpha beta t cell activation
|
GO:0046631 |
15 |
0.136
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.136
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.135
|
|
|
|
regulation of macrophage derived foam cell differentiation
|
GO:0010743 |
14 |
0.135
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.135
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
4 |
0.134
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
40 |
0.134
|
Rat |
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.134
|
|